To determine if the increased pool of LAG3+ Tregs observed in PI-3065 NR mice were enabling suppression within the tumour micro-environment and preventing full tumour control, mice were given anti-LAG3 antibody therapy once tumours were palpable, in combination with PI3Kδ blockade. The gene discussed is LAG3; the disease is neoplasm.